Use the Back button in your browser to see the other results of your search or to select another record.
Unsupervised exercise and mobility loss in peripheral artery disease: a randomized controlled trial |
McDermott MM, Guralnik JM, Criqui MH, Ferrucci L, Liu K, Spring B, Tian L, Domanchuk K, Kibbe M, Zhao L, Lloyd Jones D, Liao Y, Gao Y, Rejeski WJ |
Journal of the American Heart Association 2015 May 14;4(5):e001659 |
clinical trial |
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
BACKGROUND: Few medical therapies improve lower extremity functioning in people with lower extremity peripheral artery disease (PAD). Among people with PAD, we studied whether a group-mediated cognitive behavioral intervention promoting home-based unsupervised exercise prevented mobility loss and improved functional performance compared to control. METHODS AND RESULTS: One hundred ninety-four PAD participants were randomized. During months 1 to 6, the intervention group met weekly with other PAD participants and a facilitator. Group support and self-regulatory skills were used to help participants adhere to walking exercise. Ninety-percent of exercise was conducted at or near home. The control group attended weekly lectures. During months 6 to 12, each group received telephone contact only. Primary outcomes have been reported. Here we compare changes in exploratory outcomes of mobility loss (the inability to climb a flight of stairs or walk one-quarter mile without assistance), walking velocity, and the Short Physical Performance Battery. Compared to controls, fewer participants randomized to the intervention experienced mobility loss at 6-month follow-up 6.3% versus 26.5%, p = 0.002, odds ratio 0.19 (95% CI 0.06 to 0.58) and at 12-month follow-up 5.2% versus 18.5%, p = 0.029, odds ratio 0.24 (95% CI 0.06 to 0.97). The intervention improved fast-paced 4-m walking velocity at 6-month follow-up (p = 0.005) and the Short Physical Performance Battery at 12-month follow-up (p = 0.027), compared to controls. CONCLUSIONS: In exploratory analyses, a group-mediated cognitive behavioral intervention promoting unsupervised walking exercise prevented mobility loss and improved functioning at 6- and 12-month follow-up in PAD patients. CLINICAL TRIAL REGISTRATION: URL http://ClinicalTrials.gov. Unique identifier NCT00693940.
|